The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Months After COVID-19 Infection, Rheumatic-Like Symptoms Persist

Months After COVID-19 Infection, Rheumatic-Like Symptoms Persist

April 16, 2021 • By Mary Beth Nierengarten

  • Tweet
  • Email
Print-Friendly Version / Save PDF

As more people get vaccinated for COVID-19, there’s hope that the long days of a pandemic, which has claimed more than 2.5 million lives globally and 500,000 in the U.S., will soon draw to a close and allow daily life to return to normal. However, for some people, this recovery may take longer, because the lingering symptoms of COVID-19 are making it difficult for them to return to the hale state of health they enjoyed prior to contracting SARS-CoV-2.

You Might Also Like
  • German Society Updates Rheumatic Diseases Guidelines in Light of COVID-19 Pandemic
  • Some Rheumatic Diseases Tied to Higher Risk of Severe COVID-19
  • The COVID-19 Infection Inflammation Equation
Explore This Issue
April 2021
Also By This Author
  • Secukinumab Effective Across the Spectrum of Psoriatic Arthritis

The nomenclature for these patients is evolving. Long-haulers is popular, as is people with long COVID. Whichever term is used, it’s now widely recognized that many people are emerging from SARS-CoV-2 infection with persistent symptoms, and these cases are being documented in a growing number of cohort studies.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Research Says …

In China, a large cohort study found 76% of patients hospitalized with COVID-19 in Wuhan between January and May 2020 had at least one ongoing symptom six months after acute infection.1

A 2021 cohort study from Ireland found 62% of patients—both those hospitalized for acute COVID-19 infection and those with milder disease—reported they didn’t feel back to full health at a median of 75 days after diagnosis. Forty-seven percent of these patients met the case definition for fatigue, independent of initial disease severity. Of the 48% of patients in the Irish study who required hospitalization for COVID-19, 4% had persistently abnormal chest X-rays.2

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Other cohort studies are documenting prolonged symptoms in people with initial mild COVID-19.3,4

To better understand these numbers, a meta-analysis pooled data from multiple studies and found 80% of patients infected with SARS-CoV-2 developed one or more long-term symptoms.5 The analysis of 47,910 patients with a confirmed diagnosis of COVID-19 from 15 studies assessed symptoms, signs or laboratory parameters two weeks or more after viral infection (range: 14–100 days). The analysis included patients with all degrees of COVID-19 severity. Table 1 describes the most common symptoms reported.

Musculoskeletal symptoms are also emerging as a common persistent issue, as reported in a systematic review documenting an array of rheumatic and neuromuscular complications supported by multi-modal imaging. The review describes the range of persistent effects of COVID-19 on muscles, nerves, joints, soft tissue and bone found on imaging. The symptoms reported by patients included arm and leg weakness, pain, numbness, joint pain and swelling with restricted motion, and severe fatigue.6

Dr. Deshmukh

Dr. Deshmukh

The study’s senior author, Swati Deshmukh, MD, assistant professor, Department of Radiology (Musculoskeletal), Northwestern University, Chicago, emphasizes the clinical implication of these findings and the increasing number of people experiencing and now living with persistent post-COVID-19 symptoms.

“Early in the pandemic, there was a focus on survival vs. death,” she says. “One year later, we need to come to terms with the fact that there are many people who have long-term medical conditions because of COVID-19. The healthcare system will need to address this new patient population, the so-called long-haulers who may require expertise from doctors of different specialties.”

To date, no one knows why some people develop persistent symptoms. But the pool of patients is growing, with a new study reporting that even patients who do not feel sick after testing positive for SARS-CoV-2 are developing long-term symptoms.7

Pages: 1 2 3 4 5 | Single Page

Filed Under: Conditions Tagged With: cough, COVID-19, dyspnea, fatigue, neuropsychiatricIssue: April 2021

You Might Also Like:
  • German Society Updates Rheumatic Diseases Guidelines in Light of COVID-19 Pandemic
  • Some Rheumatic Diseases Tied to Higher Risk of Severe COVID-19
  • The COVID-19 Infection Inflammation Equation
  • Biologic Treatment Recommendations for Rheumatic Disease Patients Who Contract COVID-19

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)